According to a market report by Lucintel, the future of the global full spectrum flow cytometry market looks promising with opportunities in the academic institutions, hospital, and bioscience company markets. The global full spectrum flow cytometry market is expected to grow with a CAGR of 8.1% from 2025 to 2031. The major drivers for this market are theadvancements in personalized medicine for high-dimensional analysis, the increased adoption of flow cytometry in oncology and immuno-oncology research, and the rising investments in academic research and biopharmaceutical r&d.
A more than 150-page report to understand trends, opportunity and forecast in full spectrum flow cytometry market to 2031 by type (up to 5 lasers, up to 3 lasers, up to 7 lasers, up to 9 lasers, and others), application (academic institutions, hospital, bioscience company, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the type category, up to 5 lasers will remain the largest segment over the forecast period due to it offers a good balance between multiplexing capability.
Within the application category, academic institutions will remain the largest segment due to research demand, advanced and high-dimensional research applications.
Download sample by clicking on full spectrum flow cytometry market
In terms of region, North America will remain the largest region over the forecast period due to the u.s. is the leading consumer of full-spectrum flow cytometry systems.
Cytek, Thermo Fisher Scientific, Bd Biosciences, Sony Biotechnology, Expec Technology are the major suppliers in the full spectrum flow cytometry market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]To get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Estrogen Replacement Therapy Market
Adoptive Cell Therapy Market
Antiretroviral Therapy Market
Clear Aligner Therapy Market